# First in Humans to Evaluate Collagen Patches With Stem Cells in Patients With Ischemic Left Ventricular Dysfunction

> **NCT03746938** · PHASE1 · UNKNOWN · sponsor: **Viscofan** · enrollment: 10 (estimated)

## Conditions studied

- Heart Failure With Reduced Ejection Fraction

## Interventions

- **DEVICE:** VB-C01

## Key facts

- **NCT ID:** NCT03746938
- **Lead sponsor:** Viscofan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-11-13
- **Primary completion:** 2020-10-30
- **Final completion:** 2020-10-30
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2018-11-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03746938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03746938, "First in Humans to Evaluate Collagen Patches With Stem Cells in Patients With Ischemic Left Ventricular Dysfunction". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT03746938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*